Author:
Bhatia Jatinder,Greer Frank,
Abstract
Soy protein-based formulas have been available for almost 100 years. Since the first use of soy formula as a milk substitute for an infant unable to tolerate a cow milk protein-based formula, the formulation has changed to the current soy protein isolate. Despite very limited indications for its use, soy protein-based formulas in the United States may account for nearly 25% of the formula market. This report reviews the limited indications and contraindications of soy formulas. It will also review the potential harmful effects of soy protein-based formulas and the phytoestrogens contained in these formulas.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference101 articles.
1. Merritt RJ, Jenks BH. Safety of soy-based infant formulas containing isoflavones: the clinical evidence. J Nutr. 2004;134(5):1220S–1224S
2. American Academy of Pediatrics, Committee on Nutrition. Commentary on breast-feeding and infant formula, including proposed standards for formulas. Pediatrics. 1976;57(2):278–285
3. Food and Drug Administration. Rules and regulations: nutrient requirements for infant formulas. 21 CFR Part 107. Fed Regist. 1985;50:45106–45108
4. Bhatia J, Fomon ST. Formulas for premature infants: fate of the calcium and phosphorus. Pediatrics. 1983;72(1):37–40
5. Hillman LS, Chow W, Salmons SS, Weaver E, Erickson M, Hansen J. Vitamin D metabolism, mineral homeostasis, and bone mineralization in term infants fed human milk, cow milk-based formula, or soy-based formula. J Pediatr. 1988;112(6):864–874
Cited by
290 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献